Prediabetes
Prediabetes is an early stage of diabetes characterized by elevated blood glucose levels that are not yet high enough to be classified as diabetes, often associated with obesity, dyslipidemia, and hypertension, and it significantly increases the risk of developing type 2 diabetes and cardiovascular disease. Effective management largely involves lifestyle interventions aimed at weight loss.
Health Outcomes
- Atherogenic Lipid Profile
- Characterized Carbohydrate Metabolism Enzyme Activity
- Decreased Uncarboxylated to Total Osteocalcin Ratio
- Diabetes Progression
- Distinct Metabolic Profile
- Elevated Insulin Levels
- Enhanced Carbohydrate Oxidation
- Enhanced GLP-1 Secretion
- Enhanced Insulin Secretion
- Improved Adipokine Profile
- Improved Atherosclerosis-Related Cardiovascular Risk Markers
- Improved Beta-Cell Function
- Improved Bioactivity
- Improved Blood Biochemical Parameter
- Improved Blood Clinical Chemistry
- Improved Blood Glucose Concentration
- Improved Blood Glucose Control
- Improved Blood Glucose Levels
- Improved Blood Lipid Profile
- Improved Carbohydrate Metabolism
- Improved Cardiometabolic Health
- Improved Fasting Glucose Levels
- Improved Fasting Plasma Glucose
- Improved Gastrointestinal Hormone Regulation
- Improved Glucose Homeostasis
- Improved Glucose Level
- Improved Glucose Metabolism
- Improved Glucose Regulation
- Improved Glucose Response
- Improved Glucose Tolerance
- Improved Glycemia
- Improved Glycemic Control
- Improved Glycemic Response
- Improved Glycogen Synthetase Activity
- Improved HbA1c
- Improved Hemoglobin A1c Levels
- Improved High-Intensity Intermittent Exercise Performance
- Improved Hormonal Counter-Regulation
- Improved Incretin Release
- Improved Insulin Levels
- Improved Insulin Resistance
- Improved Insulin Response
- Improved Insulin Secretion
- Improved Insulin Secretion Rate
- Improved Insulin Sensitivity
- Improved Maternal Metabolic Health
- Improved Metabolic Homeostasis
- Improved Metabolic Parameters
- Improved Metabolic Profile
- Improved Metabolic Regulation
- Improved Metabolic Syndrome Remission
- Improved Plasma Glucose Control
- Improved Postprandial Glucose Levels
- Improved Protein Secretion
- Improved Satiety Hormonal Status
- Improved Satiety Index
- Improved Serum Glucose Levels
- Improved Serum Glycemia
- Improved Systemic Health
- Improved VLDL Cholesterol
- Improved Weight Loss
- Improved Weight Management
- Increased Adipose Browning
- Increased Bioactivity
- Increased Blood Glucose Levels
- Increased Branched Chain Amino Acid Levels
- Increased C-Peptide Secretion
- Increased Fasting Insulin Level
- Increased GLP-1 Levels
- Increased Glucagon-Like Peptide 1 Level
- Increased Glucose Uptake by Cells
- Increased Gut Hormone Level
- Increased Insulin Level
- Increased Insulin Resistance Level
- Increased Insulin Response
- Increased Insulin Secretion
- Increased Plasma Glucagon Level
- Increased Proportion with Normalized Hemoglobin A1c
- Increased Resistant Starch
- Increased Reversion to Normoglycemia
- Increased Serum Glucose Levels
- Increased Serum Insulin Levels
- Increased Triglyceride Level
- Increased Weight
- Increased β-Cell Area in Pancreatic Islets
- Lower Plasma Glucose Levels
- Maintained Glucose Control
- Modified Serum Metabolomic Pathways
- Multiple Health-Promoting Effects
- No Change in Body Weight or Cardiometabolic Parameters
- No Change in Body Weight or Food Consumption
- No Change in Metabolic Health
- Preserved Beta-Cell Function
- Preserved Pancreatic Beta-Cell Function
- Prevention of Obesity Transition
- Prevention of Weight Gain
- Reduced Adipocyte Senescence
- Reduced Beta Cell Function
- Reduced Beta-Cell Loss
- Reduced Blood Glucose Elevation
- Reduced Cardiovascular Risk Profile
- Reduced Coronary Heart Disease Risk
- Reduced Diabetes Incidence
- Reduced Diabetes Risk
- Reduced Exercise-Induced Glucose Levels
- Reduced Fasting Blood Glucose
- Reduced Fasting Blood Glucose Levels
- Reduced Fasting Blood Sugar Levels
- Reduced Fasting Insulin Level
- Reduced Fat Gain
- Reduced First Phase Insulin Secretion
- Reduced GIP
- Reduced Glucose Area Under the Curve
- Reduced Glucose Intolerance
- Reduced Glucose Levels
- Reduced Glucose Uptake
- Reduced Glucotoxicity
- Reduced Glycated Hemoglobin
- Reduced Glycated Hemoglobin A1c Level
- Reduced Glycation End Product Accumulation
- Reduced Glycative Stress Marker Level
- Reduced Glycemic Enzyme Inhibition
- Reduced Glycemic Index
- Reduced Glycemic Response
- Reduced Glycosylated Hemoglobin
- Reduced HOMA-IR
- Reduced HOMA-β
- Reduced HbA1c Level
- Reduced Hemoglobin A1C Level
- Reduced Hemoglobin A1c
- Reduced Hepatic Insulin Resistance
- Reduced Homeostatic Model Assessment for Insulin Resistance
- Reduced Hyperglycemic Response
- Reduced Insulin Output (90-min)
- Reduced Insulin Response
- Reduced Insulin Sensitivity
- Reduced Islet β-Cell Dysfunction
- Reduced Lysophosphatidylethanolamine 18:1 Level
- Reduced Metabolic Disease Risk
- Reduced Metabolic Dysregulation
- Reduced Metabolic Endotoxemia
- Reduced Non-Communicable Disease Risk
- Reduced Pancreatic Stress-Related Pathways
- Reduced Peak Plasma Glucose Level
- Reduced Plasma Glucose Levels
- Reduced Post-Exercise Serum Amyloid A Increase
- Reduced Postprandial Blood Glucose
- Reduced Postprandial Blood Glucose Level
- Reduced Postprandial Blood Glucose Rise
- Reduced Postprandial Glucose
- Reduced Postprandial Glucose Levels
- Reduced Postprandial Glucose Response
- Reduced Postprandial Glycemia
- Reduced Postprandial Glycemic Response
- Reduced Postprandial Insulin
- Reduced Postprandial Insulin Response
- Reduced Postprandial Triacylglycerol Response
- Reduced Prevalence of Gestational Diabetes Mellitus
- Reduced Protein Glycation
- Reduced Rapidly Digestible Starch
- Reduced Risk of Diabetes
- Reduced Sugar Craving
- Reduced Sugar-Sweetened Beverage Intake
- Reduced Systemic Endotoxemia at Rest
- Reduced Total Glycated Hemoglobin
- Reduced Two-Hour Postprandial Glucose
- Reduced Type 2 Diabetes Symptoms
- Reduced α-Glucosidase Activity
- Regulated Blood Glucose Levels
- Remission of Metabolic Syndrome
- Reversed Microbiome Metabolic Changes
- Stabilized Blood Glucose Level
- Stabilized Hemoglobin A1c Level
- Stable Antihyperglycemic Effect
- Stable Fasting Blood Sugar Level
- Stable Fasting Plasma Glucose
- Stable Glucose Metabolism Markers
- Unchanged Glycemic Control
- Unchanged Insulin Resistance